CLINICAL_TRIALS
trial_result
· 2017-08-08
Clinical Trial Update: Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome [Phase 2]
Summary
A Phase 2 study evaluated GW876008 in patients with irritable bowel syndrome. The trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Irritable Colon | Phase 2 | Status: COMPLETED